8 results
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... Daily GLP-1 Agonists ... medications to treat Type ... They work primarily ... #Pharmacology #Dosing
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
First Oral GLP-1 Agonist ... Dosing: 3 mg ... oral route by using ... drug to remain stable ... semaglutide #Diabetes #Pharmacology
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
some Cholinergic Agonists ... Produces miosis during ... #Cholinergic #Agonists ... #Pharmacology # ... Table #Summary
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
Long-Acting Beta2 Agonists ... the traditional type ... are the normal dosing ... Naming #Names #Pharmacology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... Transient K+ efflux moving ... Vaughan Williams Classification ... Block K+ channels (primarily ... #Classification
Insulin Calculations for Type 1 Diabetes 

Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
Calculations for Type ... Here's the 2 primary ... calculations used in dosing ... patients with type ... Diabetes #DM1 #Pharmacology
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
Skin Disease Classification ... Kikuchi disease • Type-I ... the context of primary ... pancreatitis, protein-losing
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
for Initiating Primary ... please refer to Table ... 5 for dosing recommendation ... Discontinuing Primary ... infections #HIVAIDS #pharmacology